IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,427,103 | -88.3% | 1,412,550 | -81.9% | 0.02% | -88.3% |
| Q2 2023 | $54,820,374 | +2.0% | 7,786,985 | -11.5% | 0.16% | -2.4% |
| Q1 2023 | $53,768,360 | +267.6% | 8,800,059 | +1880.5% | 0.17% | +122.7% |
| Q3 2020 | $14,628,000 | -69.1% | 444,342 | -74.2% | 0.08% | -75.7% |
| Q2 2020 | $47,283,000 | -53.9% | 1,722,515 | -49.7% | 0.31% | -62.9% |
| Q1 2020 | $102,535,000 | +32.0% | 3,425,226 | +22.1% | 0.83% | +104.2% |
| Q4 2019 | $77,649,000 | +444.8% | 2,805,230 | +258.2% | 0.41% | +363.6% |
| Q3 2019 | $14,254,000 | +31.0% | 783,203 | +76.5% | 0.09% | +54.4% |
| Q2 2019 | $10,880,000 | – | 443,710 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |